Craft

Valerion Therapeutics

Total Funding

$21.2 M

Valerion Therapeutics Summary

Company Summary

Overview
Valerion Therapeutics is a biotechnology company focused on the development of bio-therapeutics for orphan genetic diseases. It utilizes a proprietary cell-penetrating antibody technology to target the cytoplasm of affected tissues. The company builds a platform that can be conjugated to proteins, small molecules, and oligonucleotides providing a pathway to treat various diseases.
Type
Private
Status
Active
Founded
2007
HQ
Concord, MA, US | view all locations
Website
https://www.valerion.com/
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

1 location detected

  • Concord, MA HQ

    United States

    100 Main St #110

Footer menu